That is all I am looking for, enough now so that I can sell

New Post Public Reply Private Reply Replies (1) Message Board
petemantx grotty #47585
378
That is all I am looking for, enough now so that I can sell a few shares as necessary to live a nice lifestyle but IPIX constantly moving forward so stock price moving upward steadily from Aug/Sept onward. I don't need the big, big bucks by the end of the year but I would sure love double digit number. Then if it takes another couple of years with moderate growth or better to start recognizing the full value of our drugs I would be ecstatic.

I would settle for low double digits but I truly believe that Prurisol results alone should put us definitely in that range as the bottom of the valuation.

Of course, the 800 lb gorilla / variable is whether one of the many BPs vying for our favor is willing to pony up bucks unheard of now to secure a complete platform. They have the bucks, the need, and maybe one will have the cojones to pony up amounts never heard of before.

When Tiger Woods signed his first deal with Nike, people thought the sum was outrageous but Tiger's Dad said the following deal would make the just signed one look like chicken feed. He was right. I hope IPIX follows the same route as they sign additional deals after the first one.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ipsen's Kayfanda® Receives EU Approval for Alagille Syndrome Treatment

Updated Category News Views 67

Kayfanda® Receives Approval for Treatment in the EU Ipsen has made a noteworthy advancement in pediatric healthcare with the recent authorization of Kayfanda® (odevixibat) in the European Union (EU). This innovative treatment specifically addresses cholestatic pruritus, a painful symptom linked to Alagille Syndrome, a rare liver disorder that affects children. This...

Continue Reading
Discover the Remarkable Returns of Vulcan Materials Stock

Updated Category News Views 144

Unveiling Vulcan Materials Company Stock Performance Vulcan Materials Co. (NYSE: VMC) has been a noteworthy performer in the stock market over the past 15 years, surpassing market expectations with a commendable annual return of 15.1%. This stock has consistently outperformed the market, achieving an admirable 2.86% advantage annually. With a current market capitalization...

Continue Reading
AeroPress Launches Premium Coffee Press with Elegant Design

Updated Category News Views 332

AeroPress introduced its Premium coffee press back in 2024, and you can bet the market was watching closely. With a retail price of $149.95, this isn’t just another brewing tool; it’s a statement piece designed for those who take their morning ritual seriously. Traders buzzed about how this could impact sales in a saturated market where every new gadget fights for...

Continue Reading
Investigation Update: Walgreens Boots Alliance Class Action Lawsuit

Updated Category News Views 327

Overview of the Walgreens Boots Alliance Class Action Levi & Korsinsky, LLP has raised awareness among investors regarding a class action securities lawsuit involving Walgreens Boots Alliance, Inc. This company, known for its extensive pharmaceutical and retail operations, is currently facing legal challenges that could significantly impact its investors. Class Definition...

Continue Reading
Savillex Strengthens Market Position with New Acquisition

Updated Category News Views 38

Savillex Acquires Optimum Processing to Enhance Offerings Thompson Street Capital Partners (TSCP) is proud to announce that its portfolio company, Savillex, has completed the acquisition of Optimum Processing, Inc. This strategic move is expected to elevate Savillex's position in the marketplace by combining its innovative fluid handling solutions with Optimum...

Continue Reading